Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Stang

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|June 20, 2015
Adrenal Imaging Features Predict Malignancy Better than Tumor SizeJenny Y Yoo, Kelly L McCoy, Sally E Carty, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Ad-IRF-1 induces apoptosis in esophageal adenocarcinomaGregory A Watson, Pierre E Queiroz de Oliveira, Michael T Stang, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinomaMichaele J Armstrong, Huaitao Yang, Linwah Yip, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsiesLinwah Yip, Coreen Farris, Adam S Kabaker, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Cancer Research|November 19, 2004
Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivinEva Pizzoferrato, Ye Liu, Andrea Gambotto, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
World Journal of Surgery|October 2, 2013
Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?Laura I Wharry, Kelly L McCoy, Michael T Stang, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|June 20, 2015
Adrenal Imaging Features Predict Malignancy Better than Tumor SizeJenny Y Yoo, Kelly L McCoy, Sally E Carty, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Ad-IRF-1 induces apoptosis in esophageal adenocarcinomaGregory A Watson, Pierre E Queiroz de Oliveira, Michael T Stang, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinomaMichaele J Armstrong, Huaitao Yang, Linwah Yip, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsiesLinwah Yip, Coreen Farris, Adam S Kabaker, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Cancer Research|November 19, 2004
Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivinEva Pizzoferrato, Ye Liu, Andrea Gambotto, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
World Journal of Surgery|October 2, 2013
Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?Laura I Wharry, Kelly L McCoy, Michael T Stang, et al.
Pageof 7